Latin America-focused breast cancer genetics to improve risk prediction
Official title: Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)
Funded at University of California at Davis · NIH-11535296 · Data updated 2026-11-12
A study to understand how genetics affect breast cancer risk in Hispanic/Latina and related populations and improve a risk-prediction tool for these groups.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $8,640 |
| NIH project number | 3R01CA286650-03S3 |
| Project ID | NIH-11535296 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals of Latin American descent or with Hispanic/Latina ancestry who are concerned about breast cancer risk or have a family history.
✕Less likely to help
People without breast cancer risk factors or those who are not part of the identified populations may see limited immediate benefit.
What this research studies
This project brings together a large network of researchers and data from Latin American and U.S. populations to study genetic factors that influence breast cancer risk. By analyzing diverse genetic information, the team aims to refine risk models so they work well for non-European groups. The goal is to create better, ancestry-aware risk predictions that can guide screening and prevention for those at higher risk. The study leverages existing cohorts and partnerships to boost the power of genetic discoveries in populations that have been underrepresented. It focuses on translating genetic insights into improved risk assessment tools for clinicians and patients.
Why it matters
Potential benefit: Better, more accurate breast cancer risk predictions for diverse populations, leading to personalized screening and prevention.
How similar studies have gone: Previous studies show that including diverse populations improves the accuracy of genetic risk models for breast cancer.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Fejerman, Laura — University of California at Davis
- Study coordinator: Fejerman, Laura
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.